journal article·2024-02-28Open access

Ischemic Heart Disease as an Important Risk Factor for Depression—A Case Report

Laura Ioana Bondar, Brigitte Osser, Gyongyi Osser, Mariana Adelina Mariș, Elisaveta Ligia Piroș, Robert Almășan, Mircea Ioachim Popescu

Applied Sciences· Volume 14· Issue 5

Abstract

The link between the mind and cardiac disease has been studied throughout the ages. Patients diagnosed with ischemic heart disease may develop psychological and psychiatric symptoms such as depressed mood, anxiety, and insomnia that can drastically affect life quality. Unfortunately, during cardiac rehabilitation, there is a lack of psychiatric care. To improve a patient’s quality of life, this intriguing relationship between ischemic heart disease and depression must be closely monitored, because risk factors and pathophysiological mechanisms may be common. This case report article is about a 47-year-old Romanian woman with acute coronary syndrome revascularized with angioplasty and stent implantation 3 months ago, admitted to the Arad Emergency County Clinical Hospital, Psychiatric Department, with depressive symptoms. Our patient was treated with an antidepressant, an anxiolytic, a mood stabilizer, a hypnotic, a nootropic, aspirin, dual platelet inhibition, a beta-blocker, a converting enzyme inhibitor, a statin, and oral antidiabetics medication, as well as having psychotherapy sessions. The treatment was well tolerated, with an improvement in the social and professional functionality of the patient. In conclusion, people with ischemic heart disease have a higher risk of developing depression, but patients with depression also have a higher risk of developing ischemic heart disease. This confirms the importance of an individualized multidisciplinary approach to management because the collaboration between psychiatrists and cardiologists can be an additional benefit to patients. This article may pave the way for further research into the association between ischemic heart disease and depressive disorders, which could provide significant advantages to patients. Interdisciplinarity contributes to the development of innovative techniques of prevention and treatment, reducing worldwide morbidity and mortality.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cardiac Health and Mental Health · Takotsubo Cardiomyopathy and Associated Phenomena · Heart Rate Variability and Autonomic Control

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania

Faculty of Physical Education and Sport, “Aurel Vlaicu” University of Arad, 310130 Arad, Romania

Department of Biology and Life Sciences, “Vasile Goldiș” Western University of Arad, 310048 Arad, Romania

References (28)

Show source-provided references
1. Kang, W., and Malvaso, A. (2023). Mental Health in Coronary Heart Disease (CHD) Patients: Findings from the UK Household Longitudinal Study (UKHLS). Healthcare, 11.10.3390/healthcare11101364 ↗
2. Psychiatric issues in cardiovascular disorders10.4103/indianjpsychiatry.indianjpsychiatry_42_22 ↗
3. Soul, mind, brain: Greek philosophy and the birth of neuroscience10.1016/j.brainresbull.2006.09.020 ↗
4. World Health Organization (2023, December 19). Depressive Disorder (Depression). Available online: http://www.who.int/news-room/fact-sheets/detail/depression.
5. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care10.1002/j.2051-5545.2011.tb00014.x ↗
6. Geerts, K., Bongers, I., Buitenweg, D., and van Nieuwenhuizen, C. (2020). Quality of Life of People with Severe Mental Health Problems: Testing an Interactive Model. Int. J. Environ. Res. Public Health, 17.10.3390/ijerph17113866 ↗
7. Dobrek, L., and Głowacka, K. (2023). Depression and Its Phytopharmacotherapy—A Narrative Review. Int. J. Mol. Sci., 24.10.3390/ijms24054772 ↗
8. Amadio, P., Zarà, M., Sandrini, L., Ieraci, A., and Barbieri, S.S. (2020). Depression and Cardiovascular Disease: The Viewpoint of Platelets. Int. J. Mol. Sci., 21.10.3390/ijms21207560 ↗
9. Depression and the Link with Cardiovascular Disease10.3389/fpsyt.2016.00033 ↗
10. Nuraeni, A., Suryani, S., Trisyani, Y., and Sofiatin, Y. (2023). Efficacy of Cognitive Behavior Therapy in Reducing Depression among Patients with Coronary Heart Disease: An Updated Systematic Review and Meta-Analysis of RCTs. Healthcare, 11.10.3390/healthcare11070943 ↗
11. Anxious distress in depressed outpatients: Prevalence, comorbidity, and incremental validity10.1016/j.jpsychires.2018.05.006 ↗
12. Smith, S.F., and Lilienfeld, S.O. (2017). Reference Module in Neuroscience and Biobehavioral Psychology, Elsevier.
13. Combined therapy of mixed dyslipidemia in patients with high cardiovascular risk and changes in the lipid target values and atherogenic index of plasma10.1016/j.crvasa.2014.01.003 ↗
14. Predicting bipolar disorder I/II in individuals at clinical high-risk: Results from a systematic review10.1016/j.jad.2023.01.045 ↗
15. Romero-Martínez, Á., Murciano-Martí, S., and Moya-Albiol, L. (2019). Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review. Behav. Sci., 9.10.3390/bs9050057 ↗
16. Cardiovascular safety profile of tianeptine10.1016/j.rpsm.2019.04.002 ↗
17. Cardiac rehabilitation improves the ischemic burden in patients with ischemic heart disease who are not suitable for revascularization10.1016/j.carrev.2015.05.001 ↗
18. Psychiatric and Psychological Interventions for Depression in Patients with Heart Disease: A Scoping Review10.1161/JAHA.120.018686 ↗
19. The evolution of behaviour therapy and cognitive behaviour therapy10.1016/j.brat.2014.10.006 ↗
20. International consensus statement on major depressive disorder10.4088/JCP.9058se1c.08gry ↗
21. The relationship between coronary artery disease and depression and anxiety scores
22. Gan, Y., Gong, Y., Tong, X., Sun, H., Cong, Y., Dong, X., Wang, Y., Xu, X., Yin, X., and Deng, J. (2014). Depression and the risk of coronary heart disease: A meta-analysis of prospective cohort studies. BMC Psychiatry, 14.10.1186/s12888-014-0371-z ↗
23. Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis10.1155/2013/695925 ↗
24. Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis10.1097/PSY.0000000000000626 ↗
25. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)10.1093/eurheartj/ehw106 ↗
26. Reversing the downward spiral for people with severe mental illness through educational innovations10.1002/wps.20377 ↗
27. Sobolewska-Nowak, J., Wachowska, K., Nowak, A., Orzechowska, A., Szulc, A., Płaza, O., and Gałecki, P. (2023). Exploring the Heart–Mind Connection: Unraveling the Shared Pathways between Depression and Cardiovascular Diseases. Biomedicines, 11.10.3390/biomedicines11071903 ↗
28. Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease10.1016/j.neubiorev.2020.06.031 ↗